Allogeneic cell therapies offer scalability but require expanded infrastructure to build a viable commercial foundation ...

Reduced-volume bioburden testing represents a practical and defensible approach for low-volume, high-value cell and gene ...

Drug sponsors seek to capitalize on opportunities created by streamlined regulations for biosimilar characterization.

Sanofi says integrated continuous purification is a “universal solution” for downstream processing as it prepares for ...

Examine the use of CHT™ XT Media, a ceramic hydroxyapatite mixed-mode resin, to facilitate purification of various large ...

Dan is currently a trade media relations expert at Sartorius, and he formerly led the news domain of Bioprocess International ...

University students attended Biotech Week Boston Campus to learn about career options in a volatile biopharma industry and ...